Levosulpiride Eg

Levosulpiride, the active ingredient in Levosulpiride Eg, is a benzamide antipsychotic presented as an oral tablet for oral use. It is employed in the management of psychiatric conditions such as schizophrenia, depressive and anxiety disorders, as well as gastrointestinal motility disorders including functional dyspepsia and gastroparesis.

GNH USA supplies Levosulpiride Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and providing regulatory‑compliant documentation for global distribution.

Levosulpiride is indicated for several psychiatric and gastrointestinal disorders that involve dopaminergic pathways.

Schizophrenia: reduces positive symptoms and improves overall psychotic profile. Depressive disorders: augments antidepressant response in patients with depressive symptoms. Anxiety disorders: alleviates anxiety manifestations associated with dopaminergic dysregulation. Functional dyspepsia: enhances gastric emptying and relieves upper‑abdominal discomfort. Gastroparesis: promotes gastric motility and reduces nausea in delayed gastric emptying.

Levosulpiride may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Drowsiness - Dry mouth - Constipation - Weight gain - Increased prolactin levels - Nausea

Serious or Rare Side Effects: - Extrapyramidal symptoms - Tardive dyskinesia - Neuroleptic malignant syndrome - Severe hyperprolactinemia - Cardiac arrhythmias - Severe allergic reactions (anaphylaxis)

Levosulpiride requires careful consideration of patient‑specific factors and monitoring for adverse events.

Pregnancy: safety not established; avoid unless benefits outweigh risks. Breastfeeding: unknown; consider discontinuation. Elderly: monitor for increased sensitivity to side effects. Renal impairment: dose adjustment may be required. Concomitant CNS depressants: may enhance sedation. Store at ambient temperature: keep in original container, protect from moisture and light.

Levosulpiride can interact with other medicines, necessitating assessment of interaction severity.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Antipsychotics with strong D2 antagonism: additive extrapyramidal effects. - CYP450 inhibitors (e.g., ketoconazole): increase levosulpiride plasma levels.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may worsen constipation. - CNS depressants (e.g., benzodiazepines): enhanced sedation. - SSRIs: potential for serotonin syndrome (rare).